𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Building a better understanding of the intracellular tyrosine kinase PTK6 — BRK by BRK

✍ Scribed by Patrick M. Brauer; Angela L. Tyner

Book ID
113486743
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
322 KB
Volume
1806
Category
Article
ISSN
0304-419X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast tumor kinase (Brk/PTK6) plays a r
Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
✍ J. Tupper; M. R. Crompton; A. J. Harvey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 228 KB

Breast Tumor Kinase (Brk/PTK6) has a relatively limited expression profile in normal tissue. Its expression is restricted to epithelial cells that are differentiating such as those in the epidermis, and Brk expression appears to be absent from proliferating cells in normal tissue. Also, there is now

PTK787/ZK222584, a tyrosine kinase inhib
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo
✍ Markus Rudin; Paul M. J. McSheehy; Peter R. Allegrini; Martin Rausch; Diana Baum 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

## Abstract Assessment of tumour vascularity may characterize malignancy as well as predict responsiveness to anti‐angiogenic therapy. Non‐invasive measurement of tumour perfusion and blood vessel permeability assessed as the transfer constant, __K__^trans^, can be provided by dynamic contrast‐enha